PCS-2023: XW02 Introduction, Muscle

PCS-2023 > X > XW > XW0 > XW02

XW0	Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
XW02	Introduction, Muscle
XW020	Open
XW020D	Engineered Allogeneic Thymus Tissue
XW020D8	Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8
XW023	Percutaneous
XW023S	COVID-19 Vaccine Dose 1
XW023S6	Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6
XW023T	COVID-19 Vaccine Dose 2
XW023T6	Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6
XW023U	COVID-19 Vaccine
XW023U6	Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6
XW023V	COVID-19 Vaccine Dose 3
XW023V7	Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7
XW023W	COVID-19 Vaccine Booster
XW023W7	Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7
XW023X	Tixagevimab and Cilgavimab Monoclonal Antibody
XW023X7	Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
XW023Y	Other New Technology Monoclonal Antibody
XW023Y7	Introduction of Other New Technology Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7

and

Anatomical Regions, Introduction